Aging and Mutant Huntingtin Toxicity in Rats
Author Information
Author(s): Diguet Elsa, Petit Fanny, Escartin Carole, Cambon Karine, Bizat Nicolas, Dufour Noëlle, Hantraye Philippe, Déglon Nicole, Brouillet Emmanuel
Primary Institution: Commissariat à l'Energie Atomique (CEA), Institut d'Imagerie Biomédicale (I2BM), Molecular Imaging Research Center (MIRCen), Orsay, France
Hypothesis
Does normal aging affect the neurotoxicity of mutant huntingtin in Huntington's disease?
Conclusion
The study found that aging increases the neurotoxicity of mutant huntingtin in rats, suggesting that age-related cellular defects may be therapeutic targets for Huntington's disease.
Supporting Evidence
- Aging increases the number of small aggregates of mutant huntingtin in the brain.
- Older rats showed a greater loss of striatal neurons when exposed to mutant huntingtin.
- The study suggests that age-related cellular defects could be targeted for therapeutic interventions in Huntington's disease.
Takeaway
As rats get older, they are more affected by a harmful protein related to Huntington's disease, which means that aging makes the disease worse.
Methodology
The study used stereotaxic injections of lentiviral vectors in young and old rats to assess the effects of aging on mutant huntingtin toxicity.
Limitations
The study was conducted in a rat model, which may not fully replicate human Huntington's disease.
Participant Demographics
Young (3 weeks old) and old (15 months old) male Sprague-Dawley rats were used.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website